PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19783684-6	2009	Pretreatment of cells with the Syk-selective inhibitor piceatannol or Syk inhibitor II, significantly inhibited the ability of IL-4 to enhance phagocytosis and cell adhesion and to delay apoptosis, and these results correlate with the ability of piceatannol to reduce Syk activation and its association with IL-4R(alpha).	3,3',4,5'-tetrahydroxystilbene	55-66	spleen associated tyrosine kinase	Homo sapiens	31-34	
19783684-6	2009	Pretreatment of cells with the Syk-selective inhibitor piceatannol or Syk inhibitor II, significantly inhibited the ability of IL-4 to enhance phagocytosis and cell adhesion and to delay apoptosis, and these results correlate with the ability of piceatannol to reduce Syk activation and its association with IL-4R(alpha).	3,3',4,5'-tetrahydroxystilbene	246-257	spleen associated tyrosine kinase	Homo sapiens	31-34	
19783684-6	2009	Pretreatment of cells with the Syk-selective inhibitor piceatannol or Syk inhibitor II, significantly inhibited the ability of IL-4 to enhance phagocytosis and cell adhesion and to delay apoptosis, and these results correlate with the ability of piceatannol to reduce Syk activation and its association with IL-4R(alpha).	3,3',4,5'-tetrahydroxystilbene	246-257	spleen associated tyrosine kinase	Homo sapiens	70-73	
19783684-6	2009	Pretreatment of cells with the Syk-selective inhibitor piceatannol or Syk inhibitor II, significantly inhibited the ability of IL-4 to enhance phagocytosis and cell adhesion and to delay apoptosis, and these results correlate with the ability of piceatannol to reduce Syk activation and its association with IL-4R(alpha).	3,3',4,5'-tetrahydroxystilbene	246-257	spleen associated tyrosine kinase	Homo sapiens	70-73